Drug intelligence / Profile preview

Ershiwuwei Feibing Wan

Development stage
Unknown
Lead developer
Xizang Ganlu Tibetan Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ershiwuwei Feibing Wan is a traditional Tibetan medicine (TTM) developed and manufactured by Xizang Ganlu Tibetan Medicine. Formulated as an oral pill, it consists of 25 distinct ingredients, including various herbs and minerals, according to traditional Tibetan pharmacological principles. It is primarily indicated for the treatment of various respiratory conditions, collectively referred to as lung diseases, such as chronic bronchitis, asthma, and pulmonary infections. The therapeutic action of the formulation is traditionally described as clearing heat, detoxifying the lungs, and alleviating cough and phlegm. It is an approved pharmaceutical product in China, holding the National Drug License Number Z54020028.

Brand names
二十五味肺病丸
Other names
Twenty-Five Flavor Lung Disease PillsErshiwuwei Feibing Pills25-Flavor Lung Disease Pills
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)VEGFA (Vascular endothelial growth factor A)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Ershiwuwei Feibing Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ershiwuwei Feibing Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call